# Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers

> **NCT04066257** · PHASE1 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tegoprazan
- **DRUG:** Metronidazole
- **DRUG:** Tetracycline
- **DRUG:** Bismuth

## Key facts

- **NCT ID:** NCT04066257
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-17
- **Primary completion:** 2019-02-22
- **Final completion:** 2019-04-25
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066257, "Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04066257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*